|Who We Are|
|Board of Directors|
|Annual Reports and Financials|
|Office of Inspector General Advisory Opinion|
FOR IMMEDIATE RELEASE
Contact: Ashley Hutton, Communications Specialist
Thursday, March 25, 2010
Patient Access Network offers assistance for patients with chronic lymphocytic leukemia (CLL)
WASHINGTON, D.C. – On April 1, 2010, Patient Access Network (PAN) Foundation will begin providing co-payment assistance for medications to underinsured patients with chronic lymphocytic leukemia (CLL). Qualified patients will be granted $5,000 per year to cover the cost of medications related to their disease.
To qualify for assistance under this fund, patients must show that they have health insurance, that their household income is under 300% of the Federal Poverty Level, and that they are being treated for chronic lymphocytic leukemia (CLL). Patients can start the application process online at www.PANfoundation.org or by calling (866)316-PANF (7263).
CLL is the most common form of leukemia found in western countries. In 2009, approximately 15,490 new cases of CLL were reported in the United States. “Many of our patients and providers voiced a need for assistance for CLL,” said Julie Reynes, PAN President. “We are pleased to be able to help patients who desperately need this assistance.”
This new fund is an expansion of PAN’s 27 existing cancer and chronic disease funds, which cover conditions such as rheumatoid arthritis, breast cancer, and colorectal cancer. PAN provides grants of $1,500-$10,000 per year to qualified patients to help pay for medications for these diseases. In 2009 PAN helped over 18,821 patients access their medications.